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Abstract
Background: When generating guidelines, quality of the evidence is tabulated to capture its several domains, often
using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. We developed a
graphic display to capture deficiencies, outliers and similarities across comparisons contained in GRADE tables.
Methods: Based on a systematic literature review capturing the effects of 32 different therapeutic comparisons on
dysmenorrhoea, we synthesised evidence quality in tables and graphs. We evaluated time taken to accurately assess
evident quality and preference for tables vs graphs.
Results: The plots provided visually striking displays of strengths and weaknesses of the evidence across the spectrum
of comparisons on a single page. Equivalent tabulated information spread over 4 pages. Participants preferred and
interpreted graphs quicker and more accurately than tables.
Conclusions: The graphic approach we developed makes interpreting evidence easier. Large tables are dry and
cumbersome to read and assimilate. When guideline statements are accompanied by these plots, they have the scope
for improving the credibility of the recommendations made, as the strength of the evidence used can be clearly seen.
Further empirical research will establish the place for graphic displays.
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Précis: GRADE plots allow easier, Quicker and more accurate identification of deficiencies in the quality of studies,
Compared to tabulated results
Resumen: Para generar guías de práctica clínica, la calidad de la evidencia se tabula, a menudo utilizando el
GRADE (Clasificación de las recomendaciones de la evaluación y desarrollo). Hemos desarrollado una pantalla
gráfica para capturar deficiencias, valores atípicos y similitudes a través de comparaciones que figuran en las tablas
GRADE.
Métodos: Basado en una revisión sistemática de la literatura para analizar los efectos terapéuticos de 32 diferentes
tratamientos en la dismenorrea, se sintetizó calidad de la evidencia en tablas y gráficos. Evaluamos tiempo
necesario para evaluar con precisión evidente calidad y preferencia por las tablas vs gráficos.
(Continued on next page)
* Correspondence: k.s.khan@qmul.ac.uk
4Centre for Health Sciences, Barts and The London School of Medicine and
Dentistry, Queen Mary University of London, London, UK
Full list of author information is available at the end of the article
© 2016 Mignini et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Mignini et al. Reproductive Health  (2016) 13:21 
DOI 10.1186/s12978-016-0130-3
(Continued from previous page)
Resultados: Los gráficos muestran fácilmente las fortalezas y debilidades de la evidencia en todo el espectro de las
comparaciones en una sola página. Los participantes prefieren los gráficos y estos son interpretados más rápido y
con más precisión que las tablas.
Conclusiones: El enfoque gráfico que hemos desarrollado hace más fácil la interpretación de la evidencia. Las
tablas son difíciles y engorrosas para leer y asimilar. Cuando los estados únicamente se acompañan de estos
gráficos, tienen la posibilidad de mejorar la credibilidad de las recomendaciones, ya que la fuerza de la evidencia
utilizada se puede ver claramente. Más investigación empírica establecerá el lugar para pantallas gráficas.
Background
When using scientific evidence for clinical decision mak-
ing, it is essential to know its quality, in order to be
confident in the recommendations [18]. The Grading of
Recommendations, Assessment, Development and
Evaluation (GRADE) is a quality assessment tool used to
evaluate limitations of the evidence and to provide an
underpinning strength to recommendations [1]. GRADE
tables describe various quality parameters including
study design, risk of bias, inconsistencies, indirectness
and imprecision, to generate an overall rating of the evi-
dence (from high to very low). To be comprehensive,
the quality parameters (criteria, factors or domains) have
to be included for each outcome and comparison separ-
ately, making the tables bulky and difficult to use [3, 20].
These could be presented as graphic displays compres-
sing a large amount of data into concise, easy to inter-
pret figures [12]. This article explores how addition of
graphic displays of evidence quality assessment to




Primary dysmenorrhoea, a common idiopathic chronic
pelvic pain syndrome of unknown aetiology [13], was
chosen as an example. We used this topic to demon-
strate the difficulties encountered when bringing to-
gether complex data on quality of the evidence on
numerous comparisons. In this systematic review we
searched electronic literature databases, including Medline,
Embase and the Cochrane Library until January 2010 [14].
Harms alerts from relevant organizations such as the
US Food and Drug Administration (FDA) and the UK
Medicines and Healthcare products Regulatory Agency
(MHRA) were also searched. We selected randomised con-
trolled trials (RCTs) which were at least single blinded, with
at least 80 % follow up at primary end point, and had a
sample size of at least 10 women in each group.
There were many interventions compared for effect on
various outcome measures. For each comparison and
outcome pair, evidence was initially graded by the study
design. We assigned all evidence a high level of quality
as it was based on a RCT design. If there were deficien-
cies in the domains risk of bias, inconsistency, indirect-
ness and effect size or its precision, the quality level was
downgraded by one level (if the deficiency was classified
as serious) or by two levels (if the deficiency was classi-
fied as very serious). An example of an evidence profile
is shown in Table 1. The full tabulation of the evidence
profile spread over 4 pages (over 1,500 words).
Graphically displaying evidence profiles
Radar charts were used to summarise data concerning
several variables in a two-dimensional graph. Each chart
is made up of a number of spokes or radii, each repre-
senting a variable, arranged at equal angles. Three or
more quantitative variables can be represented in this
way for summarising quality parameters of clinical
evidence.
A radar chart, or GRADE plot, consisting of the five
most important GRADE quality parameters (study de-
sign, risk of bias, inconsistency, indirectness and impre-
cision of effect size) was created for each comparison
and clinical outcome. The length of a spoke was propor-
tional to the magnitude of the quality of that parameter,
ranging from serious deficiency (no spoke) to no defi-
ciency (full spoke) (Table 1) [9, 12]. If all quality parame-
ters were of high magnitude, a GRADE plot will be of
symmetrical pentagon shape. However, if one of the pa-
rameters was deficient, the shape of the pentagon will be
distorted and the cross-sectional area will be smaller.
GRADE plots were constructed based on a variety of
treatments for pelvic pain.
Overall quality of the evidence is rated by GRADE
using the following categories, high, moderate, low and
very low. We utilised a traffic light colour coding scheme
to represent this grading scale on GRADE plots. The fol-
lowing colours were allocated for each rating: green for
high quality evidence, yellow for moderate, red for low/
very low and white where evidence had no quality rating
available. Colour coding of the data used to construct
the GRADE plots and the area covered within the plot
provided additional visual information regarding the
quality of the evidence rating. Data for GRADE plots
were double checked to avoid error.
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Table 1 The features of evidence grading captured in a GRADE plot (adapted from Evid Based Med 2011;16:65-9)
Grade Design Risk of bias Inconsistency Indirectness Effect size Evidence
Quality
Studies are either described as
randomised-control
trials (RCTs) or observational.
Explains the limitations of the study
based on assessment of blinding
and allocation process, follow-up
and withdrawals, scarcity of data,








Presence of indirectness in the
PICO elements that affect the
generalisability of participants
and outcomes from each study
to population of interest.
Relates to imprecision of the
estimated effect based on the
reported odds ratios or relative
risks or mean differences for
comparison. This is based on
the confidence intervals, sample
size and number of events.
High Randomised controlled trial No problems All/most studies show
similar results with or
inconsistency across




Effect size more than 5 or less
than 0.2 for all studies/meta-
analyses included in comparison
and significant





Effect size more than 2 or less
than 0.5 for all studies/meta-
analyses included in comparison
and significant
Low/Very low Controlled observational study Problem with 2 or more elements Serious lack of agreement
between studies
Some problem with 2 or more
elements
Not all effect sizes more than 2
or less than 0.5 and significant;





Randomised trial No limitations Consistent Indirect Precise Moderate
Initially assigned a high strength
level
→ No Change → No change → Relegation → No change ┘












Quality of evidence on pelvic pain
Figure 1 shows the quality of the evidence for agents com-
monly used to treat dysmenorrhoea. When comparing sin-
gle agents against placebo or no treatment, we found that
the quality of the evidence ranged from moderate to low/
very low. Most of the comparisons assessed had a high risk
of bias and none of them directly compared interventions
which we were interested in or measured outcomes im-
portant to patients. Moreover, none of comparisons had an
adequately large and precise effect size.
Head to head comparisons of different active agents
for the treatment of pelvic pain highlighted many gaps
in the evidence base. Deficiencies in quality were seen in
the majority of data plotted (Fig. 1). There was only one
high quality comparison (LUNA vs. diagnostic laparos-
copy) that complied with all the quality items assessed.
All the remaining comparisons were of low/very low
quality. Non steroidal anti inflammatory drugs (NSAIDs)
[2, 7, 8, 15, 19] and hormonal regulation through oral
contraceptive pills [22] were significantly more effective
for pain relief than placebo. Despite poor quality these
interventions remain in common use [5, 21]. Further-
more, there was severe risk of bias and all but one com-
parison showed an inadequate effect size.
The GRADE plots immediately captured evidence
quality, for example, there was moderate quality (yellow
light) evidence of the effectiveness of Thiamine and
Iranian herbal medicine for treating dysmenorrhoea and
for the others treatment therapies there were low to very
Fig. 1 Effect of various treatments on pelvic pain: Graphic overview of evidence quality. Each graph represents the quality domains shown on
concentric spokes. Starting from 12 o’clock and moving clockwise these are design, risk of bias, inconsistency of results, indirectness of participants, and
outcomes and effect size [12]. For each of the spokes, the length represents the magnitude of quality adapting the scoring system used for Clinical
Evidence reviews (http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665072.html). The block shapes, formed by joining the lengths of the spokes,
colour coded to represent the overall quality of evidence as follows: Green = high quality evidence; yellow =moderate quality; and red = low or very low
quality. See main text of our Clinical Evidence review [14] for details. NSAIDs = non steroidal anti inflammatory drugs TENS = transcutaneous electric
nerve stimulation LUNA = laparoscopic uterine nerve ablation. * The lack of a clinically meaningful effect of LUNA for dysmenorrhoea has been
confirmed through an individual patient data meta-analysis [6]
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low quality evidence GRADE plots depicted in red.
When therapies were compared head to head, there was
only one high quality comparison (green light), which
suggested that LUNA (laparoscopic uterosacral nerve
ablation) should not be undertaken as a treatment for
dysmenorrhoea as surgery was not found superior to no
intervention. Other comparisons provided weaker rec-
ommendations, again also highlighted in red.
An empirical evaluation comparing tables vs graphs
We conducted a small randomised evaluative study to de-
termine whether researchers and clinicians interpreted
graphs quicker and more accurately than tables. Their
preference for one or the other of the two approaches was
also assessed. Prior to randomisation participants were
shown a powerpoint presentation which explained the
GRADE quality assessment tool and the new graphic con-
cept. Seventeen participants (7 researchers and 10 hospital
doctors) were then randomly assigned to either the inter-
vention group (graphs) or the control group (tables). Par-
ticipants in the intervention group were presented with a
summary figure of 10 graphs summarising 5 quality pa-
rameters (study design, risk of bias, inconsistency, indir-
ectness and imprecision). The overall quality of the
evidence was indicated with the aid of colours (green for
high overall quality, yellow for moderate and red for low
and very low). The participants were then asked 10 ques-
tions regarding the quality of the evidence. Participants in
the control group were presented with the same informa-
tion and asked the same questions, but this time sum-
marised in tables. The time taken to complete the
questionnaire was recorded in seconds with the aid of a
stopwatch. The preference between graphs or tables was
then recorded.
We found that on average graphic displays were inter-
preted quicker and more accurately than tables (see
Fig. 2), however the numbers of participants were too
small to draw any statistically significant inferences. The
majority of the participants preferred graphs to tables.
Among those who received graphs 7/9 indicated a pref-
erence for graphs vs 6/8 amongst those who received
tables.
Discussion
Although the GRADE quality assessment tool is not
used universally, it has been utilised by some large
guideline producing bodies including WHO (World
Health Organization) and NICE (National Institute for
Clinical Excellence). Currently, the summaries of
GRADE quality assessments are presented in lengthy ta-
bles that often slow the reader down in interpretation of
the findings. GRADE plots can summarise quality as-
sessment in a more concise explicable way, making it
quicker to decide on the value of the evidence. It is also
possible to arrange the results of multiple interventions
and outcomes in a compressed manner that can be eas-
ily examined and compared. The quality is further made
explicit in the graphs by use of colour-coding, which is a
strength of this approach.
There has been empirical research comparing tables
and graphs of equivalent data. The compositional for-
mat and content of quantitative data displays has an
impact on people’s comprehension, choice and prefer-
ence. [11] Our evaluative study showed that partici-
pants preferred and interpreted graphs quicker and
more accurately than tables. One deficiency of our
work is that we did not cover every single aspect of
the GRADE approach. We also modified some aspects
of GRADE to create this exemplar. For further devel-
opment aspects such as publication bias and criteria
for upgrading or downgrading will need to be add-
itionally considered, while strictly adhering to the
GRADE system. Another consideration should be the
balance of benefit vs risk of harm. It is important to
remember that the underlying concept behind the
graphs is to visualise the GRADEing for the ease of as-
similation by users, not to replace the in-depth ana-
lysis and consideration necessary for formulation of
recommendations. Further, it is necessary to recognise
the pilot or preliminary nature of our empirical evalu-
ation. Stronger empirical work will be required to ad-
vance the advantages of graphs that show potential in
our work.
Brewer et al. found that patients needed to see bar
charts for a shorter amount of time compared to tables
to understand the same results [4]. Bauer et al. also con-
cluded that physicians worked significantly faster with
the graphical display than tables [3]. The overall quality
of the evidence can be colour coded with a traffic light
system also used to display health economic data. [17].
The use of colour is not only eye-catching but if used
appropriately can allow the reader to capture the overall
quality immediately [11]. This idea is supported by the
results of a trial by Hawley et al. who found that colour
graphical representation of results (pictographs) were
the most effective way of conveying information [10].
McCaffery et al. agree with these findings. Their trial re-
ported that in adults with lower education and literacy,
pictographs were the best format for displaying numera-
tors of less than 100 (<100/1000), and bar charts were
best for larger numerators (>100/1000) [16]. We there-
fore suggest that this strength of evidence and resulting
recommendations could easily be demonstrated with a
colour-coded system.
Conclusion
GRADE plots can be used to summarise large
amounts of data in a concise, easy to interpret way.
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They demonstrate the quality parameters of study
design, risk of bias, indirectness, inconsistencies and
imprecision. The colour coded cross sectional area
of the pentagon represents the overall quality of the
evidence, also highlighting the strength of the rec-
ommendation. These plots provide a useful means of
visually displaying evidence that could be adopted
alongside the GRADE approach. The summary ob-
tained through the plots can be read at a glance to
immediately identify deficient areas that can be ex-
plored further with GRADE tables. Based on our
findings, we would like to suggest to guideline
makers to use graphic displays when summarising
and publishing conclusions on multiple comparisons
and outcomes.
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Fig. 2 Comparison of accuracy and time taken to interpret equivalent Grade tables (above) and graphs (below)
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